These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 10080346)

  • 1. Cytomegalovirus retinitis in transition.
    Tay-Kearney ML; French M; Mallal S
    Aust N Z J Ophthalmol; 1999 Feb; 27(1):89. PubMed ID: 10080346
    [No Abstract]   [Full Text] [Related]  

  • 2. Protease inhibitors linked to drop in CMV retinitis.
    AIDS Alert; 1997 Aug; 12(8):92-4. PubMed ID: 11364475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HIV drugs allow immune system to rebound, fight CMV.
    Optom Vis Sci; 2000 Jan; 77(1):3. PubMed ID: 10654853
    [No Abstract]   [Full Text] [Related]  

  • 5. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
    Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK
    Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of HIV-infected patients with cytomegalovirus retinitis under highly active antiretroviral therapy. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    Binquet C; Saillour F; Bernard N; Marimoutou C; Dabis F
    AIDS; 1998 Dec; 12(18):2502-4. PubMed ID: 9875592
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of combination antiretroviral therapy on cytomegalovirus retinitis.
    Banker AS; Patel A
    Indian J Ophthalmol; 2002 Mar; 50(1):29-33. PubMed ID: 12090084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy.
    Jacobson MA; Schrier R; McCune JM; Torriani FJ; Holland GN; O'Donnell JJ; Freeman WR; Bredt BM
    J Infect Dis; 2001 May; 183(9):1399-404. PubMed ID: 11294673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMV after HAART.
    Posit Aware; 1998; 9(5):18, 23. PubMed ID: 11365888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV+ patients.
    van den Horn GJ; Meenken C; Danner SA; Reiss P; de Smet MD
    Br J Ophthalmol; 1998 Sep; 82(9):988-90. PubMed ID: 9893585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved outcome of cytomegalovirus retinitis in AIDS patients after introduction of protease inhibitors.
    Casado JL; Perez-Elías MJ; Martí-Belda P; Antela A; Suarez M; Ciancas E; Frutos B; Perez MD; Guerrero A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):130-4. PubMed ID: 9768621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New treatments for HIV].
    Garcia E
    Sidahora; 1996; ():48-50. PubMed ID: 11363630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome.
    Karavellas MP; Lowder CY; Macdonald C; Avila CP; Freeman WR
    Arch Ophthalmol; 1998 Feb; 116(2):169-75. PubMed ID: 9488268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy.
    Nguyen QD; Kempen JH; Bolton SG; Dunn JP; Jabs DA
    Am J Ophthalmol; 2000 May; 129(5):634-9. PubMed ID: 10844056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
    Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
    J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of cytomegalovirus (CMV)-specific CD4+ T lymphocyte reactivity and protective immunity against acquired immunodeficiency syndrome-related CMV retinitis.
    Jacobson MA; Bredt BM
    J Infect Dis; 2002 Dec; 186(11):1701-2; author reply 1702-3. PubMed ID: 12447752
    [No Abstract]   [Full Text] [Related]  

  • 19. Negative result of cytomegalovirus blood culture with restoration of CD4+ T-cell reactivity to cytomegalovirus after HAART in an HIV-1-infected patient.
    Li TS; Tubiana R; Fillet AM; Autran B; Katlama C
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(5):514-5. PubMed ID: 10225236
    [No Abstract]   [Full Text] [Related]  

  • 20. Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS.
    Tanguilig GG; Rutzen AR; Ortega-Larrocea G
    Am J Ophthalmol; 1998 Apr; 125(4):567-8. PubMed ID: 9559752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.